Kanadevia Corp. (HIZOF)
OTC
Closed
Aug 24, 2026
Day's Range
7.7052 wk Range
6.56Overview - HIZOF - Kanadevia Corp.
Key Statistics
Valuation
Enterprise Value
421.46M
P/E (Trailing)
‪18.78‬
Price / Sales (TTM)
‪0.0019‬
Price / Book
‪1.05‬
EV / EBITDA
‪0.01‬
Profitability
Profit Margin
‪2.24%‬
Operating Margin
‪-1.69%‬
Return on Assets
‪1.39%‬
Return on Equity
‪7.75%‬
Ownership
Shares Outstanding
168.25M
Float
156.06M
Held by Insiders
‪1.77%‬
Held by Institutions
‪60.23%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪7.70‬
200-Day Avg
‪7.16‬
Dividends
Payout Ratio
‪37.75%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HIZOF - Kanadevia Corp.
Peers - HIZOF - Kanadevia Corp.
Peer Comparison
Compared with companies in Pollution & Treatment Controls listed on OTC.
Profile Summary - HIZOF - Kanadevia Corp.
About
Kanadevia Corp. is a pharmaceutical company specializing in the research, development, and commercialization of innovative healthcare solutions. The primary function of the company is to address unmet medical needs through its diverse range of products and therapies. With a focus on biotechnology, Kanadevia Corp. is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
